New findings could lead to drugs that fight back when tumors don't respond to treatme

[News]

Cancer drugs known as ErbB inhibitors have shown great success in treating many patients with lung, breast, colon and other types of cancer. However, ErbB drug resistance means that many other patients do not respond, and even among those who do, tumors commonly come back...

More... (http://www.medicalnewstoday.com/releases/264509.php)